Charlotte Kvasnovsky
Charlotte Kvasnovsky
Cohen Children's Medical Center
Verified email at
Cited by
Cited by
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
K Dheda, K Shean, A Zumla, M Badri, EM Streicher, L Page-Shipp, ...
The Lancet 375 (9728), 1798-1807, 2010
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
T Dalton, P Cegielski, S Akksilp, L Asencios, JC Caoili, SN Cho, ...
The Lancet 380 (9851), 1406-1417, 2012
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
TCG for the Meta, N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, ...
The Lancet 392 (10150), 821-834, 2018
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers
MR O'Donnell, J Jarand, M Loveday, N Padayatchi, J Zelnick, L Werner, ...
Annals of internal medicine 153 (8), 516-522, 2010
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study
A Sharma, A Hill, E Kurbatova, M van der Walt, C Kvasnovsky, TE Tupasi, ...
The Lancet Infectious Diseases 17 (7), 707-715, 2017
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two …
EV Kurbatova, JP Cegielski, C Lienhardt, R Akksilp, J Bayona, ...
The Lancet Respiratory medicine 3 (3), 201-209, 2015
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis
JP Cegielski, T Dalton, M Yagui, W Wattanaamornkiet, GV Volchenkov, ...
Clinical Infectious Diseases 59 (8), 1049-1063, 2014
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection
MR O’Donnell, N Padayatchi, C Kvasnovsky, L Werner, I Master, ...
Emerging infectious diseases 19 (3), 416, 2013
Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance
JP Cegielski, E Kurbatova, M Van Der Walt, J Brand, J Ershova, T Tupasi, ...
Clinical Infectious Diseases 62 (4), 418-430, 2016
Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease
CL Kvasnovsky, U Aujla, I Bjarnason
Scandinavian journal of gastroenterology 50 (3), 255-263, 2015
Increased diverticular complications with nonsteriodal anti‐inflammatory drugs and other medications: a systematic review and meta‐analysis
CL Kvasnovsky, S Papagrigoriadis, I Bjarnason
Colorectal Disease 16 (6), O189-O196, 2014
Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients
CL Kvasnovsky, JP Cegielski, R Erasmus, NO Siwisa, K Thomas, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (2), 146-152, 2011
Extensively drug‐resistant tuberculosis (XDR‐TB) among health care workers in South Africa
J Jarand, K Shean, M O’Donnell, M Loveday, C Kvasnovsky, ...
Tropical Medicine & International Health 15 (10), 1179-1184, 2010
Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study
CM Yuen, EV Kurbatova, T Tupasi, JC Caoili, M Van Der Walt, ...
PLoS medicine 12 (12), e1001932, 2015
Elderly patients have more infectious complications following laparoscopic colorectal cancer surgery
CL Kvasnovsky, K Adams, M Sideris, J Laycock, AK Haji, A Haq, ...
Colorectal Disease 18 (1), 94-100, 2016
Global Preserving Effective TB Treatment Study (PETTS) Investigators. Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis
JP Cegielski, T Dalton, M Yagui, W Wattanaamornkiet, GV Volchenkov, ...
Clin Infect Dis 59 (8), 1049-63, 2014
Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study
CL Kvasnovsky, LEX Leong, JM Choo, GCJ Abell, S Papagrigoriadis, ...
European journal of gastroenterology & hepatology 30 (1), 107-112, 2018
A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease
CL Kvasnovsky, I Bjarnason, AN Donaldson, RA Sherwood, ...
Inflammopharmacology 25 (5), 499-509, 2017
Contrasting pattern of chronic inflammatory bowel disease in primary and autoimmune sclerosing cholangitis
I Bjarnason, B Hayee, P Pavlidis, C Kvasnovsky, A Scalori, G Sisson, ...
EBioMedicine 2 (10), 1523-1527, 2015
Limiting hospital resources for acute appendicitis in children: Lessons learned from the US epicenter of the COVID-19 pandemic
CL Kvasnovsky, Y Shi, BS Rich, RD Glick, SZ Soffer, AM Lipskar, S Dolgin, ...
Journal of Pediatric Surgery, 2020
The system can't perform the operation now. Try again later.
Articles 1–20